Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 47 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
Cryohealth from Schilde, company number BE0790558215, closed financial year 2024 with a result of € -234,715 after tax. For that financial year Cryohealth recorded a gross margin of € 54,505 and equity of € 43,122. Compared with financial year 2023, the result moved from € 75,442 to € -234,715. The company made a loss. The buffer shrank hard: equity is 84 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 26, 2025.
€ 43,122
▼ 84% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -234,715
▼ still € 75,442 profit in 2023
Profit after tax over the fiscal year.
€ 4,025
▼ 71% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -159,274.
People and assets in 2024
€ 33,339
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,707
▼ 24% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 26,953
▼ 95% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 19,248
▲ 37% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 122,824 | € 54,505 | ▼ 56% |
| Profit after taxes | € 75,442 | € -234,715 | ▼ € 310,157 |
| Equity | € 277,838 | € 43,122 | ▼ 84% |
| Total debts | € 700,810 | € 763,601 | ▲ 9% |
| Cash | € 13,655 | € 4,025 | ▼ 71% |
| Land & buildings | - | € 208,456 | |
| Retained profit | € 75,442 | € -159,274 | ▼ € 234,715 |
| Balance sheet total | € 978,648 | € 806,723 | ▼ 18% |
Key figures of Cryohealth, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Cryohealth?
What happened at Cryohealth in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New establishment in Antwerpen. KBO
- New annual accounts for financial year 2024: loss of € 234,715 (▼ € 310,157 vs 2023). filed late Source: NBB ↗
- New establishment in Schilde. KBO
- Start of the company according to the CBE. KBO
In short
From € 75,442 profit in 2023 to € 234,715 loss in 2024.
Paid € 14,062 in corporate taxes since 2023.
Best year ever: 2023, with € 75,442 profit.
A new publication or filing at Cryohealth? We notify you, reason included.
Follow CryohealthDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of 2XU GROUP, PROPORT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
CryohealthBehind Cryohealth are Xander Denys, Bracke-Porters V.O.F. and 2XU Group BV. The shares are held by 2XU GROUP (40%) and PROPORT (18.3%).
Directors
According to the 2024 annual accounts
Xander Denys
Director
Director · represented by Dieter Bracke
Director · represented by Louis Ballegeer
Also active at: SIVAC, J. & F. DE LAET, INTELLIGENT NUTRITION, DILITO, STIMMER, ELP, Transformics, CONCEPTZ +4 more
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Turnhoutsebaan 330-332
2970 Schilde
Riemstraat 47
2000 Antwerpen
Active since 5 January 2026
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Google Workspace
Hosting
DSTNY-BACKBONE International Backbone, BE
Website info
Features
Security
Details
- Company number
- 0790.558.215
- VAT number
- BE 0790.558.215
- Registered office
- Turnhoutsebaan 330-332, 2970 Schilde
- Names & denominations
- Cryohealth
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 September 2022
- Peppol
- Active · Active since 2 Sept 2023
- Contact
- cryohealth.be [email protected]
- Activities · NACE
Activiteiten van overige sportclubs
Overige detailhandel in nieuwe artikelen neg